APOGOSSYPOL

ID: ALA551288

Max Phase: Preclinical

Molecular Formula: C28H30O6

Molecular Weight: 462.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc2c(C(C)C)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)cc2c1O

Standard InChI:  InChI=1S/C28H30O6/c1-11(2)21-15-7-13(5)23(25(31)17(15)9-19(29)27(21)33)24-14(6)8-16-18(26(24)32)10-20(30)28(34)22(16)12(3)4/h7-12,29-34H,1-6H3

Standard InChI Key:  PBJKWGWHZVXBGU-UHFFFAOYSA-N

Associated Targets(Human)

BCL2L1 Tchem Apoptosis regulator Bcl-X (2604 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCL2A1 Tchem Bcl-2-related protein A1 (291 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCL1 Tchem Induced myeloid leukemia cell differentiation protein Mcl-1 (3820 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCL2 Tclin Apoptosis regulator Bcl-2 (3787 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCL2L2 Tchem Apoptosis regulator Bcl-W (121 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (8692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 462.54Molecular Weight (Monoisotopic): 462.2042AlogP: 6.76#Rotatable Bonds: 3
Polar Surface Area: 121.38Molecular Species: NEUTRALHBA: 6HBD: 6
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.68CX Basic pKa: CX LogP: 7.29CX LogD: 7.27
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.19Np Likeness Score: 0.72

References

1. Wei J, Kitada S, Rega MF, Stebbins JL, Zhai D, Cellitti J, Yuan H, Emdadi A, Dahl R, Zhang Z, Yang L, Reed JC, Pellecchia M..  (2009)  Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.,  52  (14): [PMID:19555126] [10.1021/jm900472s]
2. Zhang L, Jiang H, Cao X, Zhao H, Wang F, Cui Y, Jiang B..  (2009)  Chiral gossypol derivatives: evaluation of their anticancer activity and molecular modeling.,  44  (10): [PMID:19447525] [10.1016/j.ejmech.2009.04.025]
3. Zhang L, Jiang H, Cao X, Zhao H, Wang F, Cui Y, Jiang B..  (2009)  Chiral gossypol derivatives: evaluation of their anticancer activity and molecular modeling.,  44  (10): [PMID:19447525] [10.1016/j.ejmech.2009.04.025]
4.  (2015)  Naphthalene-based inhibitors of anti-apoptotic proteins, 
5. Nhu D, Lessene G, Huang DCS, Burns CJ.  (2016)  Small molecules targeting Mcl-1: the search for a silver bullet in cancer therapy,  (5): [10.1039/C5MD00582E]
6. Yang S, Mao Y, Zhang H, Xu Y, An J, Huang Z..  (2019)  The chemical biology of apoptosis: Revisited after 17 years.,  177  [PMID:31129454] [10.1016/j.ejmech.2019.05.019]
7. Gampe C, Verma VA..  (2020)  Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.,  63  (23.0): [PMID:32916044] [10.1021/acs.jmedchem.0c01177]
8. Liu T, Wu Z, He Y, Xiao Y, Xia C..  (2020)  Single and dual target inhibitors based on Bcl-2: Promising anti-tumor agents for cancer therapy.,  201  [PMID:32563811] [10.1016/j.ejmech.2020.112446]